Search

Search Constraints

You searched for: Author/Creator Pizzoferrato, Marco

Search Results

1. Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy. (1st February 2022)

2. COVID-19 and intestinal inflammation: Role of fecal calprotectin. Issue 11 (November 2020)

3. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. Issue 7 (August 2020)

4. Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease centre. Issue 7 (1st August 2020)